These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9577734)

  • 21. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of rapid prescreening and 100% rapid review as internal quality control methods for cervical cytopathology.
    Tobias AHG; Vitalino AC; Rezende MT; Oliveira RRR; Coura-Vital W; Amaral RG; Carneiro CM
    Cytopathology; 2018 Oct; 29(5):428-435. PubMed ID: 29904955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
    Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personal performance profiles: a useful adjunct to quality assurance in cervical cytology.
    Houliston DC; Boyd CM; Nicholas DS; Smith JA
    Cytopathology; 1998 Jun; 9(3):162-70. PubMed ID: 9638377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technologic advances for evaluation of cervical cytology: is newer better?
    Hartmann KE; Nanda K; Hall S; Myers E
    Obstet Gynecol Surv; 2001 Dec; 56(12):765-74. PubMed ID: 11753179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of re-screening of cervical smears in internal quality control.
    Baker A; Melcher D; Smith R
    J Clin Pathol; 1995 Nov; 48(11):1002-4. PubMed ID: 8543619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of false-negative Papanicolaou smears by rapid rescreening in a large routine cervical cytology laboratory.
    Wright RG; Halford JA; Ditchmen EJ
    Pathology; 1999 Nov; 31(4):379-81. PubMed ID: 10643010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance characteristics of rapid (30-second) prescreening. Implications for calculating the false-negative rate and comparison with other quality assurance techniques.
    Renshaw AA; Cronin JA; Minter LJ; Nappi D; Whitman T; Jiroutek M; Cibas ES
    Am J Clin Pathol; 1999 Apr; 111(4):517-22. PubMed ID: 10191772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
    Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
    Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid rescreening.
    Rubin A
    Cytopathology; 1998 Apr; 9(2):141-2. PubMed ID: 9577744
    [No Abstract]   [Full Text] [Related]  

  • 34. Internal quality assurance in cervical cytology one laboratory's experience.
    Cross PA
    Cytopathology; 1996 Feb; 7(1):25-31. PubMed ID: 8833871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invited commentary--Rapid review: current practice.
    Faraker CA
    Cytopathology; 2001 Aug; 12(4):249-50. PubMed ID: 11488873
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined cytology and colposcopy to screen for cervical cancer in pregnancy.
    Guerra B; De Simone P; Gabrielli S; Falco P; Montanari G; Bovicelli L
    J Reprod Med; 1998 Aug; 43(8):647-53. PubMed ID: 9749413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
    Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population.
    McKinnon KJ; Ford RM; Hunter JC
    Int J STD AIDS; 1991; 2(4):276-9. PubMed ID: 1655057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.